Rein Therapeutics, Inc. Common Stock RNTX Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Returns | |||||
| Return on assets | -115.5%-40.7pp | -74.8%-50.2pp | -24.6%+53.0pp | -77.5%+3.2pp | |
| Efficiency | |||||
| Asset turnover | 0×— | 0×— | 0×— | 0×— | |
| Liquidity | |||||
| Current ratio | 0.7×-1.7× | 2.4×-1.8× | 4.2×-2.3× | 6.5×-4.2× | |
| Quick ratio | 0.7×-1.7× | 2.4×-1.8× | 4.2×-2.3× | 6.5×-4.2× | |
| Cash ratio | 0.5×-1.7× | 2.2×-1.7× | 4×+2.4× | 1.5×+0.7× | |
| Valuation | |||||
| Market capitalization | $88.96M+164% | —— | —— | —— | |
| Earnings yield | -59.2%+125pp | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Rein Therapeutics, Inc. Common Stock's ratios come from?
- Every ratio is computed from Rein Therapeutics, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.